US biotech firm completes 95% of dodo genome, targets bird’s possible revival

 Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies. By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits. With 95% of the dodo genome analysis complete, their ambitious project is on track, though a specific timeline for the living dodo remains undisclosed. This groundbreaking venture is part of a larger initiative to counteract the effects of human-induced species extinction. Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies. By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits. With 95% of the dodo genome analysis complete, their ambitious project is on track, though a specific timeline for the living dodo remains undisclosed. This groundbreaking venture is part of a larger initiative to counteract the effects of human-induced species extinction.